Ingrid Glimelius

49PUBLICATIONS
132CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersExercise physiologyGenomics and transcriptomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Aug 25, 2026
Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non-Hodgkin Lymphoma on Reproduction Patterns.

|Apr 13, 2026
Complications and clinical outcomes of retroperitoneal lymph node dissection for testicular cancer in a centralized population-based cohort in Sweden: insights from SWENOTECA.

Anna Thor, Anna Grenabo Bergdahl, Armin Abniki

|Apr 01, 2026
AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma.

Ninja Övergaard, Kjersti Lia, Jeremia Collin

|Jan 09, 2026
Survival in mantle cell lymphoma patients burdened by a second primary malignancy.

Kossi D Abalo, Trine Trab, Joachim Baech

|Dec 26, 2025
Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases.

Klaus Rostgaard, Stephen Hamilton-Dutoit, Kristina L Lauridsen

|Dec 21, 2025
High-dose chemotherapy in male germ cell cancer patients-a study by the SWENOTECA group.

Anna K Jansson, Gabriella Cohn-Cedermark, Helene F S Negaard

Pageof 9

Frequent Collaborators

9 joint publications

Caroline E Weibull

8 joint publications

Sandra Eloranta

7 joint publications

Martin Hutchings

6 joint publications

Peter Hollander